- Home>
- Specialties>
- HIV/AIDS Clinical Care>
- Adherence
Search for Adherence in HIV/AIDS Clinical Care
Physician-authored summaries on the latest research on adherence, editorials on adherence, and perspectives on adherence - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 258 results - Relevance
- Date
You searched for: adherence in HIV/AIDS
-
The Number of Doses Matters in Adherence
- February 9, 2009
- Paulina Rebolledo, MD, MSc, and Carlos del Rio, MD
- HIV/AIDS
A meta-analysis of 11 randomized, controlled trials suggests that adherence is better with once-daily than with twice-daily regimens.- Reviewing:
- Parienti J-J et al., Clin Infect Dis 2009 Feb 15; 48:484.
-
Antidepressants, ART Adherence, and HIV Outcomes
- February 25, 2008
- Valerie Stone, MD, MPH
- HIV/AIDS
In a retrospective study, treating depression seemed to attenuate, or even eliminate, the negative effects of this condition on ART adherence and HIV outcomes.- Reviewing:
- Horberg MA et al., J Acquir Immune Defic Syndr 2007 Dec 13;:
-
Virologic Failure: The Roles of Race, Adherence, and Quality of Life
- December 3, 2007
- Carlos del Rio, MD
- HIV/AIDS
In ACTG 5095, nonadherence to efavirenz-containing regimens increased risk for virologic failure in blacks but not in whites.- Reviewing:
- Schackman BR et al., J Acquir Immune Defic Syndr 2007 Dec 15; 46:547. Pence BW et al., J Acquir Immune Defic Syndr 2007 Nov 8;:
-
How Much Adherence Is Enough? Free
- July 2, 2007
- Carlos del Rio, MD
- HIV/AIDS
In two new studies, moderate adherence to an NNRTI- or boosted-PI–based regimen often led to sustained virologic suppression.- Reviewing:
- Nachega JB et al., Ann Intern Med 2007 Apr 17; 146:564-73. Shuter J et al., J Acquir Immune Defic Syndr 2007 May 1; 45:4-8.
-
Do NNRTI-Based Regimens Work at <95% Adherence?
- October 23, 2006
- Keith Henry, MD
- HIV/AIDS
Among homeless HIV-infected patients, viral suppression was more likely to be achieved with NNRTI-based therapy than with unboosted PI-based therapy, even when adherence was <95%.- Reviewing:
- Bangsberg DR., Clin Infect Dis 2006 Oct 1; 43:939-41. Gulick RM., Clin Infect Dis 2006 Oct 1; 43:942-4.
-
Adherence to Antiretroviral Therapy: Africa vs. North America Free
- September 1, 2006
- Keith Henry, MD
- HIV/AIDS
A meta-analysis of adherence studies yielded a pooled estimate of 77% adequate adherence in Africa versus 55% in North America.- Reviewing:
- Mills EJ et al., JAMA 2006 Aug 9; 296:679-90.
-
Case Management Found to Improve Adherence and CD4-Cell Counts
- July 17, 2006
- Keith Henry, MD
- HIV/AIDS
In an observational study of HIV-infected people with unstable housing, increased use of case management was linked to greater medication adherence and increased CD4-cell counts.- Reviewing:
- Kushel MB et al., Clin Infect Dis 2006 Jul 15; 43:234-42.
-
Do Adherence Interventions Make a Difference?
- May 31, 2006
- Carlos del Rio, MD
- HIV/AIDS
Two studies shed light on the potential effectiveness of adherence interventions in high-risk populations.- Reviewing:
- Wohl AR et al., Clin Infect Dis 2006 Jun 1; 42:1619-27. Lucas GM et al., Clin Infect Dis 2006 Jun 1; 42:1628-35. Flanigan TP and Mitty JA., Clin Infect Dis 2006 Jun 1; 42:1636-8.
-
Lopinavir/Ritonavir Forgives Poor Adherence
- July 13, 2005
- Abigail Zuger, MD
- HIV/AIDS
Less than perfectly adherent patients had better virologic suppression with a regimen containing lopinavir/r than one containing nelfinavir.- Reviewing:
- King MS et al., J Infect Dis 2005 Jun 15; 191:2046-52.
-
Diminished CD4-Cell Recovery in Older Patients Despite Good Adherence
- September 22, 2008
- Keith Henry, MD
- HIV/AIDS
A small retrospective study highlights the importance of detecting HIV early in older individuals.- Reviewing:
- Brañas F et al., Am J Med 2008 Sep; 121:820.
-
Pharmacy Records: A Substitute for Viral-Load Monitoring in Resource-Poor Settings? Free
- June 30, 2008
- Abigail Zuger, MD
- HIV/AIDS
Low adherence may predict virologic failure better than do changes in CD4-cell count.- Reviewing:
- Bisson GP et al., PLoS Med 2008 May 20; 5:e109.
-
Does High Baseline Viral Load Predict Treatment Outcomes?
- June 28, 2006
- Paul E. Sax, MD
- HIV/AIDS
In patients with baseline CD4 counts ≥200 cells/mm3, baseline viral load did not predict survival, so long as adherence to antiretroviral therapy was 95% or better.- Reviewing:
- Wood E et al., AIDS 2006 May 12; 20:1117-23. Mussini C., AIDS 2006 May 12; 20:1197-8.
-
Are Adherence Interventions Cost-Effective?
- May 1, 2004
- G. Sonia Nagy, MD
- HIV/AIDS
This mathematical model suggests that even only slightly effective adherence interventions are likely to be cost-effective in populations at the greatest risk of disease progression.- Reviewing:
- Goldie SJ et al., Am J Med 2003 Dec 1; 115:632-41.
-
Check Adherence before Switching Drugs
- March 1, 2000
- Abigail Zuger, MD
- HIV/AIDS
Two studies suggest that when a regimen begins to fail, low drug levels or poor adherence, rather than drug resistance, may be responsible.- Reviewing:
- Descamps D et al., JAMA 2000 Jan 12; 283:
205 211 . Havlir D et al., JAMA 2000 Jan 12; 283:229 234 . Markowitz M., JAMA 2000 Jan 12; 282:250 251 .
-
Patient Adherence and Response to Therapy
- August 1, 1999
- Paul E. Sax, MD
- HIV/AIDS
Patient self-report of adherence strongly predicts viral load and CD4 response to antiretroviral therapy; providers once again make poor estimates of their patients' behavior.- Reviewing:
- Haubrich RH et al., AIDS 1999 Jun 18; 13:
1099 1107 .
-
When Your Patient Is Too Busy to Take Meds Free
- May 18, 2009
- HIV/AIDS
Two experts describe how they would encourage adherence in an AIDS patient already overburdened with work and family responsibilities. -
Outcomes of ART in South Africa Are Similar to Those in Switzerland Free
- August 18, 2008
- Gerald H. Friedland, MD
- HIV/AIDS
New study results should make it clear to any remaining doubters that antiretroviral therapy can be provided successfully in resource-limited settings in sub-Saharan Africa.- Reviewing:
- Keiser O et al., PLoS Med 2008 Jul 8; 5:e148.
-
Expanded HIV Treatment in Resource-Poor Countries Free
- December 29, 2006
- HIV/AIDS
Initial concerns that antiretroviral therapy would be less effective in resource-poor settings ― or that patients there would be less adherent ― appear to be unfounded. -
Report from ICAAC, 2006
- October 30, 2006
- HIV/AIDS
ICAAC did not generate much substantial HIV news in 2006, but a few presentations were noteworthy. -
A Patient with Multiple Resistance Mutations and a History of Nonadherence
- October 16, 2006
- HIV/AIDS
Two experts discuss the pharmacologic and psychological challenges of managing this patient’s HIV.
Sort by:
Items 1 to 20 of 258 results - Relevance
- Date


